# CASTLE (Clopidogrel And Serum Troponin Level Elevation)

> **NCT00716924** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 155 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00716924
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2006-02
- **Final completion:** —
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2009-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716924, "CASTLE (Clopidogrel And Serum Troponin Level Elevation)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00716924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*